Platelet Glycoprotein

Sample type: Serum
Optimal result: 0.6 – 1.8 ELISA Index

ANTIBODIES ASSOCIATED WITH:
This test by itself is not diagnostic for any condition or disease

Arterial Thrombosis
Autoimmune Thrombocytopenia
Cardiovascular Disease
Coronary Artery Disease
Systemic Lupus Erythematosus (SLE)

BODY TISSUE:

Cardiovascular and Endocrine

When a biomarker like Platelet Glycoprotein is below the reference range but still marked as "optimal," it typically indicates the following considerations:

  1. Reference Range vs. Optimal Range:

    • The reference range represents the values seen in a population, including healthy and potentially at-risk individuals. Values below or above this range can be flagged as abnormal.
    • The optimal range is a narrower range based on values typically associated with better health outcomes. A value outside the reference range but within the optimal range might reflect individual variability or a less concerning finding.
  2. Clinical Context:

    • In autoimmune testing, a low Platelet Glycoprotein level might not always signify disease. It could be a normal finding for that specific patient, particularly if they are not showing symptoms of platelet-related issues, like clotting abnormalities or bleeding disorders.
  3. Immune Modulation:

    • Some autoantibodies, such as those targeting Platelet Glycoprotein, may fluctuate depending on the immune system's state. A value slightly below the reference range but deemed "optimal" might suggest no significant immune reactivity against platelets at the time of testing.
  4. Test Sensitivity and Precision:

    • Certain panels are designed to detect early or subtle immune changes. A result labeled as optimal below the reference range might mean the value is not clinically significant for the patient's overall health or current condition.
  5. Marker-Specific Interpretation:

    • For Platelet Glycoprotein, it is essential to evaluate other markers in the panel and the patient’s clinical presentation. A single low value might not warrant concern unless accompanied by other abnormal findings, such as elevated autoantibodies against multiple markers or clear symptoms.

If there’s ongoing uncertainty or the patient has symptoms potentially related to platelet function (e.g., excessive bleeding, bruising, or clotting issues), consulting with a healthcare provider can help contextualize the finding further.

ANTIBODIES ASSOCIATED WITH:
This test by itself is not diagnostic for any condition or disease

Arterial Thrombosis
Autoimmune Thrombocytopenia
Cardiovascular Disease
Coronary Artery Disease
Systemic Lupus Erythematosus (SLE)

BODY TISSUE:

Cardiovascular and Endocrine

Platelet Glycoprotein: Marker Overview

Platelet Glycoprotein is a crucial component of the platelet membrane, playing an integral role in platelet adhesion, aggregation, and overall hemostasis (the process of blood clot formation). It includes a family of glycoproteins (e.g., GP IIb/IIIa, GP Ib-IX-V) that are involved in binding fibrinogen, von Willebrand factor (vWF), and other molecules necessary for proper clot formation.

Importance in Autoimmune Testing:

In the context of autoimmune reactivity screening, antibodies against Platelet Glycoprotein may indicate an autoimmune reaction affecting platelet function, potentially leading to platelet dysfunction or destruction. This can be associated with various autoimmune or hematologic disorders.


Clinical Relevance of Platelet Glycoprotein:

  1. Associated Conditions:

    • Immune Thrombocytopenic Purpura (ITP): Autoantibodies targeting platelet glycoproteins can lead to platelet destruction, resulting in low platelet counts and increased bleeding risk.
    • Drug-Induced Thrombocytopenia: Certain medications can trigger autoantibody formation against platelet glycoproteins.
    • Antiphospholipid Syndrome (APS): Autoimmune conditions that may involve platelet glycoprotein reactivity.
    • Autoimmune Hemolytic Disorders: These conditions may also involve immune-mediated platelet destruction.
  2. Symptoms of Abnormal Glycoprotein Reactivity:

    • Easy bruising or excessive bleeding
    • Petechiae (small, pinpoint red or purple spots on the skin)
    • Prolonged bleeding after injury or surgery
    • Rarely, thrombotic complications (in autoimmune hypercoagulable states)

Marker Behavior in Autoimmune Reactivity Screening:

  • Elevated Levels or Reactivity: May suggest autoimmune activity or the presence of antibodies targeting platelet glycoproteins. This could indicate an underlying condition like ITP or APS.
  • Low Levels Below Reference Range:
    • Not necessarily pathological; may simply reflect individual variability or low autoimmune reactivity at the time of testing.
    • If marked "optimal," it often suggests no significant immune system activity against platelet glycoproteins.

Why Is This Marker Important in Array 5?

The Array 5 Multiple Autoimmune Reactivity Screen focuses on detecting early autoimmune activity across multiple organ systems. Testing for Platelet Glycoprotein antibodies is critical in identifying platelet-targeted immune responses, which may provide early warnings of autoimmune or hematologic conditions before clinical symptoms manifest.

Key Takeaways:

  • A low or "optimal" level of Platelet Glycoprotein indicates that no significant autoimmune activity targeting platelets is currently present.
  • Elevated levels or abnormal reactivity might warrant further investigation to rule out platelet dysfunction, thrombocytopenia, or other autoimmune conditions.

Monitoring this marker in conjunction with other markers and clinical symptoms can help provide a comprehensive understanding of the patient's immune and hematologic health.

Platelet Glycoprotein
Healthmatters dashboard showing biomarker trend graph

Every lab result you’ve ever had, charted and explained.

Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.

Start with my report →
Beyond Platelet Glycoprotein — 10,000+ markers explained
One Platelet Glycoprotein result tells you where you are. Your history tells you where you’re heading. Upload your past lab reports and see this marker — and every marker on them —every marker charted against your own lab’s ranges.
Start with this report →
Healthmatters timeline preview showing biomarker trends over time
Clinical Sources & References

All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.

Article Review Log
Written by Healthmatters Editorial Team
Healthmatters Lifetime Plan

Pay $250. Track your health forever

One payment. No renewals. Yours for life.

10,000+ biomarkers explained · trends over time

See other plans →
Secure checkout via Stripe · GDPR & HIPAA
We accept results from any lab
LabCorp Quest Diagnostics Genova Diagnostics DUTCH Test Doctor's Data Vibrant America ZRT Laboratory Cyrex Labs + any other lab

What members are saying

★★★★★ 10,000+ happy members
★★★★★

"Watching my numbers move over the years — instead of forgetting last time's results — completely changed how I manage my health."

Daniel
Member since 2022
★★★★★

"Living across several countries made keeping my lab results organized a real challenge. Healthmatters brought my results from the USA, Spain, and Germany together — 20 years of history, with long-term trends instead of scattered reports."

Ben
Member since 2021 · tracks across countries
★★★★★

"Standard lab ranges are too wide for how I practice — 'normal' isn't optimal. I set my own bands, so a client sees yellow before a marker goes officially out of range. That's the conversation I want to be having."

Dr. Alexandra
Functional medicine · 6 yrs on Pro